Quality Policy System
Transparency
Organisational structure
Contact points
About us
Links
F.A.Q.
Events
Contact
Sightless version
RSS
Sitemap
Magyar
News
Supervision
Inspection
GMP Inspections
GLP Inspections
GCP Inspections
GDP Inspections
Pharmacovigilance Inspection
Pharmacovigilance
Definitions
How could adverse effects be recognized?
Spontaneous report of adverse effects
PSUR
Clinical report of adverse effects
Eudravigilance
Pharmacovigilance requirements
Counterfeit medicines
Advertisement control
Methodology
Pharmaceutical methodology
NIP medicine reviewers
Pharmacopoeia Hungarica VIII
Formulae Normales VII
Drug information
Drug database
Lists
Paramedicines
Expiry date extension
Temporary discontinuation of sale
Rapid Alert
Withdrawal from the market
Laws and regulations
Finance
Forms
Impressum
Editors:
Annamária Gara, Franciska Szabó
ogyi@ogyi.hu
Last updated: 2008.09.15 11:42
printer version
National Institute of Pharmacy
| H-1051 Budapest, Zrínyi u. 3. | Mail: 1372 P.O. Box: 450.
Tel: +36 1 88 69 -300 | Fax: +36 1 88 69-460 |
Impressum
|
Copyright
Opening hours for docketing: Monday to Thursday: 8.30-12.00, Friday: 8.30-11.00
